切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2020, Vol. 17 ›› Issue (08) : 742 -747. doi: 10.3877/cma.j.issn.1672-6448.2020.08.006

所属专题: 文献

浅表器官超声影像学

桥本甲状腺炎合并良恶性结节的超声特征比较分析
侯怡卿1, 钱乐1, 杨志芳1, 张静雯1, 詹维伟,1()   
  1. 1. 200025 上海交通大学医学院附属瑞金医院超声诊断科
  • 收稿日期:2019-10-11 出版日期:2020-08-01
  • 通信作者: 詹维伟

Comparison of ultrasonographic characteristics of Hashimoto's thyroiditis with benign and malignant thyroid nodules

Hou Hou1, Qian Qian1, Yang Yang1, Zhang Zhang1, Zhan Zhan,1()   

  1. 1. Department of Ultrasonography, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China
  • Received:2019-10-11 Published:2020-08-01
  • Corresponding author: Zhan Zhan
引用本文:

侯怡卿, 钱乐, 杨志芳, 张静雯, 詹维伟. 桥本甲状腺炎合并良恶性结节的超声特征比较分析[J]. 中华医学超声杂志(电子版), 2020, 17(08): 742-747.

Hou Hou, Qian Qian, Yang Yang, Zhang Zhang, Zhan Zhan. Comparison of ultrasonographic characteristics of Hashimoto's thyroiditis with benign and malignant thyroid nodules[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2020, 17(08): 742-747.

目的

探讨桥本甲状腺背景下伴有甲状腺恶性结节与伴有良性结节的腺体实质超声表现的不同,以鉴别桥本甲状腺炎合并结节的良恶性。

方法

回顾性选取2012年12月至2019年6月在上海瑞金医院行甲状腺手术、经病理确诊为桥本甲状腺炎且术前超声影像资料完整的患者456例。以术后病理结果为"金标准",将患者分为桥本甲状腺炎合并良性结节组175例;桥本甲状腺炎合并恶性结节组281例。对2组的甲状腺腺体大小、实质回声类型及实质血供进行比较分析。

结果

合并恶性结节的患者甲状腺两腺叶的前后径、左右径及峡部厚度均小于合并良性结节的患者(P均<0.01)。恶性结节组甲状腺实质最常见的回声类型为网格样改变(112/281,39.9%),而良性结节组最常见的为斑片状减低(80/175,45.7%)。良性结节组中斑片状减低型和结节样改变型的占比大于恶性结节组,差异均有统计学意义(χ2=3.986、4.100,P均<0.05),恶性结节组的网格样改变型占比大于良性结节组,且差异有统计学意义(χ2=4.818,P<0.05)。恶性结节组最常见的是血供类型为无明显改变或轻度增多型(180/281,64.1%),占比大于良性结节(64/175,36.6%);良性结节组最常见的血供类型为中度增多型(85/175,48.6%),占比大于恶性结节(61/281,21.7%);2组间比较差异均有统计学意义(χ2=32.748、35.753,P均<0.01)。

结论

形态较小、实质呈网格样改变、血供正常或轻度增加的桥本甲状腺炎腺体背景更易伴发恶性结节,腺体的超声影像学评估有助于桥本甲状腺炎合并结节的良恶性鉴别。

Objective

To compare the ultrasonographic features of thyroid parenchyma of patients with Hashimoto thyroiditis (HT) concomitant with benign and malignant thyroid nodules to investigate if features of thyroid parenchyma can help diagnose malignant nodules in patients with HT.

Methods

A total of 456 patients who had HT concomitant with thyroid nodules and underwent thyroidectomy at Shanghai Ruijin Hospital between December 2012 and June 2019 were retrospectively included. The patients were divided into two groups: HT with benign nodules (n=175) and HT with malignant nodules (n=281). The size of the thyroid gland and echo type and blood supply of thyroid parenchyma were evaluated and compared between the two groups.

Results

The anteroposterior diameter, transverse diameter, longitudinal diameter, and isthmus thickness of thyroid lobes in patients with malignant nodules were smaller than those in patients with benign nodules (P<0.01). The most common echo type of thyroid parenchyma in the malignant group was grid like changes (112/281, 39.9%), while the most common type in the benign group was micronodular hypoechoic changes (80/175, 45.7%). The percentages of patients with micronodular hypoechoic changes and nodular changes in the benign group were significantly higher than those in the malignant group (χ2=3.986 and 4.100, P<0.05). The percentage of patients with grid like changes in the malignant group was significantly higher than that in the benign group (χ2=4.818, P<0.05). The most common type of blood supply in the malignant group was normal or slight increase of blood supply (180/281, 64.1%), which was significantly more frequent than that in the benign group (64/175, 36.6%; χ2=32.748, P<0.01). In the benign group, moderately increased blood supply of the parenchyma is the most common type (85/175, 48.6%), which was significantly more frequent than that in the malignant group (61/281, 21.7%; χ2=35.753, P<0.01).

Conclusion

Evaluating the sonographic features of thyroid parenchyma is helpful to differentiate benign and malignant nodules in patients with HT. A smaller size of the thyroid gland and normal or slightly increased blood supply with grid like changes of the parenchyma often indicate a greater chance of having malignant nodules.

图1 甲状腺实质回声分型超声图像。图a为无明显改变型;图b为弥漫性减低型;图c为斑片状减低型;图d为网格样改变型;图e为结节样改变型
图2 甲状腺实质血供分型超声图像。图a为无明显改变或轻度增加型;图b为中等程度增多型;图c为明显增多型;图d为明显减少型
表1 桥本甲状腺合并恶性结节组与合并良性结节组的甲状腺径线大小比较[mm,MQR)]
表2 桥本甲状腺合并恶性结节组与合并良性结节组的甲状腺实质回声比较[例(%)]
表3 桥本甲状腺合并恶性结节组与合并良性结节组的甲状腺实质血供比较[例(%)]
1
Ragusa F, Fallahi P, Elia G, et al. Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33(6): 101367.
2
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
3
Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland[J]. AMA Arch Surg, 1955, 70(2): 291-297.
4
Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement[J]. Radiology, 2005, 237(3): 794-800.
5
Gul K, Dirikoc A, Kiyak G, et al. The association between thyroid carcinoma and Hashimoto's thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules[J]. Thyroid, 2010, 20(8): 873-878.
6
Singh B, Shaha AR, Trivedi H, et al. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome[J]. Surgery, 1999, 126(6): 1070-1077.
7
Resende de Paiva C, Grønhøj C, Feldt-Rasmussen U, et al. Association between Hashimoto's Thyroiditis and Thyroid Cancer in 64,628 Patients[J]. Front Oncol, 2017, 7: 53.
8
Lai X, Xia Y, Zhang B, et al. A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk[J]. Oncotarget, 2017, 8(37): 62414-62424.
9
杨志芳,詹维伟,周建桥. 超声对桥本甲状腺炎甲状腺微小乳头状癌的诊断价值[J/CD]. 中华医学超声杂志(电子版), 2014, 11(10): 840-844.
10
黄伟钦,薛恩生,林礼务, 等. 桥本甲状腺炎背景下甲状腺癌的超声表现探讨[J/CD]. 中华医学超声杂志(电子版), 2009, 6(3): 531-538.
11
Kim HG, Kim EK, Han KH, et al. Pathologic spectrum of lymphocytic infiltration and recurrence of papillary thyroid carcinoma[J]. Yonsei Med J, 2014, 55(4): 879-885.
12
Stuart A. The changing scene in Hashimoto's disease: a review[J]. Med Hypotheses, 2011, 77(3): 424-426.
13
Fiore E, Rago T, Latrofa F, et al. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine[J]. Endocr Relat Cancer, 2011, 18(4): 429-437.
14
Silva de Morais N, Stuart J, Guan H, et al. The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer[J]. J Endocr Soc, 2019, 3(4): 791-800.
15
Kim ES, Lim DJ, Baek KH, et al. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules[J]. Thyroid, 2010, 20(8): 885-891.
16
Kang DY, Kim KH, Kim JM, et al. High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population[J]. Thyroid, 2007, 17(11): 1031-1038.
17
Willms A, Bieler D, Wieler H, et al. Correlation between sonography and antibody activity in patients with Hashimoto thyroiditis[J]. J Ultrasound Med, 2013, 32(11): 1979-1986.
18
Guarino V, Castellone MD, Avilla E, et al. Thyroid cancer and inflammation[J]. Mol Cell Endocrinol, 2010, 321(1): 94-102.
19
Radetti G, Loche S, D'Antonio V, et al. Influence of Hashimoto Thyroiditis on the Development of Thyroid Nodules and Cancer in Children and Adolescents[J]. J Endocr Soc, 2019, 3(3): 607-616.
20
Frates MC, Benson CB, Doubilet PM, et al. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules?[J]. J Ultrasound Med, 2003, 22(2): 127-134.
21
Sostre S, Reyes MM. Sonographic diagnosis and grading of Hashimoto's thyroiditis[J]. J Endocrinol Invest, 1991, 14(2): 115-121.
22
Latina A, Gullo D, Trimarchi F, et al. Hashimoto's thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer[J]. PLoS One, 2013, 8(3): e55450.
[1] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[2] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[3] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[4] 刘畅, 蒋洁, 胥雪冬, 崔立刚, 王淑敏, 陈文. 北京市海淀区医疗机构甲状腺超声检查及TIRADS分类基线调查[J]. 中华医学超声杂志(电子版), 2024, 21(07): 693-697.
[5] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[6] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[7] 项文静, 徐燕, 茹彤, 郑明明, 顾燕, 戴晨燕, 朱湘玉, 严陈晨. 神经学超声检查在产前诊断胼胝体异常中的应用价值[J]. 中华医学超声杂志(电子版), 2024, 21(05): 470-476.
[8] 胡可, 鲁蓉. 基于多参数超声特征的中老年女性压力性尿失禁诊断模型研究[J]. 中华医学超声杂志(电子版), 2024, 21(05): 477-483.
[9] 张妍, 原韶玲, 史泽洪, 郭馨阳, 牛菁华. 小肾肿瘤超声漏诊原因分析新思路[J]. 中华医学超声杂志(电子版), 2024, 21(05): 500-504.
[10] 席芬, 张培培, 孝梦甦, 刘真真, 张一休, 张璟, 朱庆莉, 孟华. 乳腺错构瘤的临床与超声影像学特征分析[J]. 中华医学超声杂志(电子版), 2024, 21(05): 505-510.
[11] 杨敬武, 周美君, 陈雨凡, 李素淑, 何燕妮, 崔楠, 刘红梅. 人工智能超声结合品管圈活动对低年资超声医师甲状腺结节风险评估能力的作用[J]. 中华医学超声杂志(电子版), 2024, 21(05): 522-526.
[12] 侯中光, 詹韵韵, 毕玉, 王佳佳, 吴瑕璧, 彭梅. 三维反转成像技术在BI-RADS 4类乳腺肿块应用中的初步研究[J]. 中华医学超声杂志(电子版), 2024, 21(04): 370-376.
[13] 袁晓峰, 惠品晶, 颜燕红, 张炎, 蔡忻懿. 椎动脉椎间段血流动力学参数评估椎动脉颅内段狭窄性病变的效能及可行性研究[J]. 中华医学超声杂志(电子版), 2024, 21(04): 399-407.
[14] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
[15] 陈秀晓, 隋文倩, 王珉鑫, 吴圆圆. 腹股沟斜疝并腹腔游离体超声表现一例[J]. 中华临床医师杂志(电子版), 2024, 18(05): 516-517.
阅读次数
全文


摘要